Castro-Skoglund Jenecsis is categorized under Internal Medicine Practitioners in Peoria, IL and active since 2001.
Castro-Skoglund Jenecsis was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Jenecsis Castro-Skoglund at the company’s single location by writing to 5401 North Knoxville Avenue, Peoria, Illinois IL 61614 or by phoning (309) 689-8370. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Castro-Skoglund Jenecsis |
Contact Person: | Jenecsis Castro-Skoglund |
Address: | 5401 North Knoxville Avenue, Peoria, Illinois 61614 |
Phone Number: | (309) 689-8370 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Castro-Skoglund Jenecsis was started in 2001 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jenecsis Castro-Skoglund for inquiries that concern Castro-Skoglund Jenecsis by calling the company number (309) 689-8370, as your correspondence is most welcome. Additionally, the physical location of the single location of Castro-Skoglund Jenecsis can be found at the coordinates as well as the street address 5401 North Knoxville Avenue in Peoria, Illinois 61614.
For its online presence, you may visit Castro-Skoglund Jenecsis’s website at and engage with its social media outlets through on Twitter and on Facebook.